Trial reportClinical oral investigations2026
Clinical outcomes of intrabony defects treated with bone graft and collagen membrane using apically incised coronally advanced surgical technique or papilla preservation technique: a randomized controlled trial.
Trial report in Clinical oral investigations, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
Abstract
objectiveThis study assessed the clinical efficacy of the combined Apically Incised Coronally Advanced Surgical Technique (AICAST), deproteinized bovine bone mineral, and a collagen membrane for guided tissue regeneration (GTR) in intrabony defects, and compared outcomes with the papilla preservation technique.
methodsA single-center, parallel-arm, randomized controlled trial was conducted involving 26 patients with 39 deep intrabony defects in patients with periodontitis. The test group (n = 23 defects) received guided tissue regeneration (GTR) using the apically incised coronally advanced surgical technique (AICAST) combined with deproteinized bovine bone mineral and a collagen membrane. The control group (n = 16 defects) received GTR using the papilla preservation technique (PPT) with the same bone graft and membrane. The primary outcome was the change in clinical attachment level (CAL) at 12 months postoperatively. Secondary outcomes included changes in probing depth (PD), bleeding on probing (BOP), plaque index (PI), papilla tip (TP) position, radiographic new bone height (NB), supracrestal new bone (SUPRA-NB), and supracrestal attachment gain (SUPRA-AG), as well as early postoperative outcomes (wound closure score, VAS pain score, and PI at 1 and 2 weeks). Clinical parameters and cone-beam computed tomography measurements were obtained at baseline and at 3 and 12 months postoperatively.
resultsBoth groups demonstrated statistically significant improvements at 3 and 12 months postoperatively in PD, BOP, PI, and CAL. The mean CAL gain at 12 months was 3.04 ± 1.10 mm in the test group and 2.88 ± 1.13 mm in the control group (between‑group difference: 0.16 mm; 95% CI: - 0.66 to 0.98; p = 0.702). At 1 and 2 weeks postoperatively, the test group exhibited significantly lower plaque index values compared with the control group (p = 0.023 and p = 0.020, respectively), indicating improved early postoperative plaque control. After 12 months, the papilla tip position demonstrated a statistically significant change in the test group (p = 0.012), whereas no significant change was observed in the control group (p = 0.764). Comparable outcomes were observed between groups with respect to new bone height, supracrestal bone formation, and clinical attachment gain. The mean increase in new bone height was 2.67 ± 1.66 mm in the test group and 3.30 ± 2.11 mm in the control group (p = 0.302).
conclusionThe combined AICAST and GTR approach was associated with significant improvements in clinical parameters in the management of intrabony defects. When compared to the conventional technique, this approach was associated with improved early plaque control and enhanced papillary position at 12 months, while achieving comparable regenerative outcomes. These findings support the use of AICAST as a viable surgical option for periodontal regeneration; further studies are warranted to evaluate its broader applicability and long-term efficacy.
Indexed as
Identifiers
42435072What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.